The impact of transcatheter aortic valve implantation (TAVI) on mitral regurgitation — a single center study
Abstract
Background: The coexistence of mitral regurgitation (MR) and severe aortic stenosis (AS) has been associated with worse outcomes in patients undergoing transcatheter aortic valve implantation (TAVI). Herein, the aim was to assess the etiology and degree of MR in an unselected TAVI population and investigate the impact of MR reduction at mid-term follow-up.
Methods: Patients subjected to TAVI as a treatment for severe AS in a single center were retrospectively analyzed. The primary endpoint was the MR reduction after TAVI. The secondary endpoint was all-cause mortality and heart failure hospitalization at a 3-year follow-up.
Results: Patients undergoing TAVI (n = 283) in the years 2017–2019 were screened for the presence of hemodynamically significant MR. Sixty-nine subjects (24.4%) with severe (16, 23.2%) and moderate (53, 76.8%) MR were included. The primary MR was predominant (39 subjects, 56.5%). The median age of the patients was 82 years. MR improved in 25 patients (36.2%, p < 0.001). Baseline severe MR was more prone to reduce (8 subjects, 50%) than moderate (17 subjects, 32.1%, p = 0.04). The primary MR improved in 14 patients (35.9%), while secondary in 11 patients (36.7%, p = 1). Patients showing MR reduction had lower mortality (8 vs. 29.55%, p = 0.047) and were less frequently hospitalized (20 vs. 45.45%, p = 0.03) at 3-year follow-up.
Conclusions: Hemodynamically significant MR improves after TAVI regardless of its etiology. Moreover, MR reduction after TAVI is associated with better clinical outcomes.
Keywords: aortic stenosismitral regurgitationTAVItranscatheter aortic valve implantationTAVRtranscatheter aortic valve replacement
References
- Rostagno C. Heart valve disease in elderly. World Journal of Cardiology. 2019; 11(2): 71–83.
- Brener SJ, Duffy CI, Thomas JD, et al. Progression of aortic stenosis in 394 patients: relation to changes in myocardial and mitral valve dysfunction. J Am Coll Cardiol. 1995; 25(2): 305–310.
- Nappi F, Nenna A, Timofeeva I, et al. Mitral regurgitation after transcatheter aortic valve replacement. J Thorac Dis. 2020; 12(5): 2926–2935.
- Kleczynski P, Brzychczy P, Kulbat A, et al. Balloon aortic valvuloplasty for severe aortic stenosis may reduce mitral regurgitation in mid-term follow-up. Postepy Kardiol Interwencyjnej. 2022; 18(3): 255–260.
- Barreiro CJ, Patel ND, Fitton TP, et al. Aortic valve replacement and concomitant mitral valve regurgitation in the elderly: impact on survival and functional outcome. Circulation. 2005; 112(9 Suppl): I443–I447.
- Takagi H, Umemoto T. All-Literature Investigation of Cardiovascular Evidence Group. Coexisting Mitral Regurgitation Impairs Survival After Transcatheter Aortic Valve Implantation. Ann Thorac Surg. 2015; 100(6): 2270–2276.
- Nombela-Franco L, Eltchaninoff H, Zahn R, et al. Clinical impact and evolution of mitral regurgitation following transcatheter aortic valve replacement: a meta-analysis. Heart. 2015; 101(17): 1395–1405.
- Chakravarty T, Van Belle E, Jilaihawi H, et al. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation. Am J Cardiol. 2015; 115(7): 942–949.
- Sannino A, Losi MA, Schiattarella GG, et al. Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis. Am J Cardiol. 2014; 114(6): 875–882.
- Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. EuroIntervention. 2022; 17(14): e1126–e1196.
- Wiktorowicz A, Kleczynski P, Dziewierz A, et al. Impact of frailty on mortality after transcatheter aortic valve implantation. Am Heart J. 2017; 185(7): 52–58.
- Wiewiórka Ł, Trębacz J, Sobczyński R, et al. Computed tomography guided tailored approach to transfemoral access in patients undergoing transcatheter aortic valve implantation. Cardiol J. 2023; 30(1): 51–58.
- Kappetein AP, Head SJ, Généreux P, et al. Updated standardized endpoint definitions for transcatheter aortic valve implantation: The Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013; 145: 6–23.
- Lancellotti P, Tribouilloy C, Hagendorff A, et al. Scientific Document Committee of the European Association of Cardiovascular Imaging. Recommendations for the echocardiographic assessment of native valvular regurgitation: an executive summary from the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2013; 14(7): 611–644.
- Mauri V, Körber MI, Kuhn E, et al. Prognosis of persistent mitral regurgitation in patients undergoing transcatheter aortic valve replacement. Clin Res Cardiol. 2020; 109(10): 1261–1270.
- Al-Lamee R, Godino C, Colombo A. Transcatheter aortic valve implantation: current principles of patient and technique selection and future perspectives. Circ Cardiovasc Interv. 2011; 4(4): 387–395.
- Nombela-Franco L, Ribeiro HB, Urena M, et al. Significant mitral regurgitation left untreated at the time of aortic valve replacement: a comprehensive review of a frequent entity in the transcatheter aortic valve replacement era. J Am Coll Cardiol. 2014; 63(24): 2643–2658.
- Zajarias A, Lisko JC, Hayek S. Zajarias A, Lisko JC, Hayek S, et al Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing Transcatheter Aortic Valve Replacement. 2020: 1–13.
- Muratori M, Fusini L, Tamborini G, et al. Mitral valve regurgitation in patients undergoing TAVI: Impact of severity and etiology on clinical outcome. Int J Cardiol. 2020; 299: 228–234.
- Al-Hindwan HS, Landmesser U, Stähli B, et al. The predictive value of a modified Carpentier classification in patients with coincidental mitral regurgitation undergoing TAVI for severe aortic valve stenosis1. Clin Hemorheol Microcirc. 2018; 70(1): 15–25.
- Ryś M, Hryniewiecki T, Witkowski A, et al. Association between calcifications of mitro-aortic continuity and mitral regurgitation in patients undergoing transcatheter aortic valve replacement. Kardiol Pol. 2021; 79(6): 669–675.
- Sarı C, Aslan AN, Baştuğ S, et al. Immediate recovery of the left atrial and left ventricular diastolic function after transcatheter aortic valve implantation: A transesophageal echocardiography study. Cardiol J. 2016; 23(4): 449–455.
- Fernandez-Santos S, Théron A, Pibarot P, et al. Valve hemodynamic performance and myocardial strain after implantation of a third-generation, balloon-expandable, transcatheter aortic valve. Cardiol J. 2020; 27(6): 789–796.
- Kasapkara HA, Ayhan H, Sarı C, et al. Impact of transcatheter aortic valve implantation on the left ventricular mass. Cardiol J. 2015; 22(6): 645–650.
- Shibayama K, Harada K, Berdejo J, et al. Effect of transcatheter aortic valve replacement on the mitral valve apparatus and mitral regurgitation: real-time three-dimensional transesophageal echocardiography study. Circ Cardiovasc Imaging. 2014; 7(2): 344–351.
- Gotzmann M, Lindstaedt M, Bojara W, et al. Hemodynamic results and changes in myocardial function after transcatheter aortic valve implantation. Am Heart J. 2010; 159(5): 926–932.
- Treibel TA, Kozor R, Schofield R, et al. Reverse Myocardial Remodeling Following Valve Replacement in Patients With Aortic Stenosis. J Am Coll Cardiol. 2018; 71(8): 860–871.
- Ribeiro HB, Lerakis S, Gilard M, et al. Transcatheter Aortic Valve Replacement in Patients With Low-Flow, Low-Gradient Aortic Stenosis: The TOPAS-TAVI Registry. J Am Coll Cardiol. 2018; 71(12): 1297–1308.
- Merten C, Beurich HW, Zachow D, et al. Aortic regurgitation and left ventricular remodeling after transcatheter aortic valve implantation: a serial cardiac magnetic resonance imaging study. Circ Cardiovasc Interv. 2013; 6(4): 476–483.
- Barbanti M, Webb JG, Hahn RT, et al. Placement of Aortic Transcatheter Valve Trial Investigators. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A. Circulation. 2013; 128(25): 2776–2784.
